Get started
TRxADE HEALTH, Inc.TRxADE HEALTH, Inc.TRxADE HEALTH, Inc.

TRxADE HEALTH, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

MEDS chart

Upcoming earnings

Next report date
Report period
Q1 2024
EPS estimate
−0.15USD
Revenue estimate
‪2.05 M‬USD

Key stats

Market capitalization
‪9.07 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−21.43USD
Net income (FY)
‪−17.84 M‬USD
Revenue (FY)
‪8.27 M‬USD
Shares float
‪848.80 K‬
Beta (1Y)
0.69

About TRxADE HEALTH, Inc.

Sector
Commercial Services
Industry
Miscellaneous Commercial Services
CEO
Surendra Ajjarapu
Website
trxadehealth.com
Headquarters
Lutz
Employees (FY)
8
Founded
2005
FIGI
BBG000RNLYM7
TRxADE HEALTH, Inc. is a health services information technology company, which focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. It operates through the following segments: Trxade, Inc., CSP, Integra, and Other. The Trxade, Inc. segment is involved in web based pharmaceutical marketplace platform B2B sales. The CSP segment refers to community specialty pharmacy, LLC – Licensed retail pharmacy B2C sales. The Integra segment consists of Integra Pharma, LLC, Licensed wholesaler of brand, generic and non-drug products B2B sales. The Other segment consists of corporate overhead expense, Alliance Pharma Solutions, LLC, and Bonum Health, LLC. The company was founded by Suren Ajjarapu and Prashant Patel on July 15, 2005 and is headquartered in Lutz, FL.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MEDS is 6.26 USD — it has decreased by 2.95% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange TRxADE HEALTH, Inc. stocks are traded under the ticker MEDS.
TRxADE HEALTH, Inc. is going to release the next earnings report on Apr 26, 2024. Keep track of upcoming events with our Earnings Calendar.
MEDS stock is 12.59% volatile and has beta coefficient of 0.69. Check out the list of the most volatile stocks — is TRxADE HEALTH, Inc. there?
MEDS earnings for the last quarter are −2.90 USD per share, whereas the estimation was −0.75 USD resulting in a −286.67% surprise. The estimated earnings for the next quarter are −0.15 USD per share. See more details about TRxADE HEALTH, Inc. earnings.
TRxADE HEALTH, Inc. revenue for the last quarter amounts to ‪2.25 M‬ USD despite the estimated figure of ‪2.06 M‬ USD. In the next quarter revenue is expected to reach ‪2.28 M‬ USD.
Yes, you can track TRxADE HEALTH, Inc. financials in yearly and quarterly reports right on TradingView.
MEDS stock has fallen by 13.66% compared to the previous week, the month change is a 41.77% fall, over the last year TRxADE HEALTH, Inc. has showed a 30.40% increase.
MEDS net income for the last quarter is ‪−11.72 M‬ USD, while the quarter before that showed ‪−3.53 M‬ USD of net income which accounts for −232.36% change. Track more TRxADE HEALTH, Inc. financial stats to get the full picture.
Today TRxADE HEALTH, Inc. has the market capitalization of ‪8.80 M‬, it has decreased by 5.67% over the last week.
Like other stocks, MEDS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TRxADE HEALTH, Inc. stock right from TradingView charts — choose your broker and connect to your account.
MEDS reached its all-time high on Aug 17, 2009 with the price of 80059.95 USD, and its all-time low was 3.69 USD and was reached on Feb 8, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has 8.00 employees. See our rating of the largest employees — is TRxADE HEALTH, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TRxADE HEALTH, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TRxADE HEALTH, Inc. stock shows the strong sell signal. See more of TRxADE HEALTH, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TRxADE HEALTH, Inc. EBITDA is ‪−6.58 M‬ USD, and current EBITDA margin is −75.11%. See more stats in TRxADE HEALTH, Inc. financial statements.